On May 8th, Ji Hong, Vice Chairman of the Xinxiang Municipal Political Consultative Conference and Chairman of the Minjian Xinxiang Municipal Committee, led a research team to Henan Zhimei Microbial Pharmaceutical Co., Ltd. to conduct work research on the "Clinical and Industrialization Research Project of Class 1.1 Anti tumor New Drug BTK Inhibitors". Zhang Changshun, Chairman of the Fengquan District Political Consultative Conference, Geng Jianwei, Deputy District Mayor of the government, and other leaders accompanied the research. 

   Wang Yuqiao, General Manager of Xinxiang Wangshi Group and Chairman of EMICRO Biomedicine Company, warmly welcomed the arrival of the research team. Yang Yinke, Chief Medical Officer of the company, and Jin Jianxin, Deputy General Manager, attended the symposium. At the symposium, the research team listened to and learned about the progress, advantages, and prospects of EMICRO Company's "1.1 class anti-tumor innovative drug BTK inhibitor TM471 project" through electronic screens, as well as the difficulties and needs currently faced. Ma Yunfei, the head of the High tech Department of the Municipal Development and Reform Commission, introduced and explained the relationship between the strategic positioning of the project and the development of new quality productivity, and put forward good suggestions for solving the financing problems of enterprises.

    姬泓主席听取汇报后，她对新乡王氏集团从水泥建材行业，向创新药研发行业转型升级的勇气和取得的成绩给予了肯定，赞扬了企业的创新精神。她说，创新药研发是造福民生利国利民的事业，新乡市委、市政府高度重视并大力支持。政协和民建新乡市委会，要发挥好参谋助手、桥梁和纽带的作用，帮助企业多了解国家惠企政策，对好项目和好政策，要帮助企业对接好、落实到位，为企业健康发展创造好环境，为促进新乡市经济建设多做贡献。